S. 4252 — Introduced in Senate

II 117th CONGRESS 2d Session S. 4252 IN THE SENATE OF THE UNITED STATES May 18 (legislative day, May 17), 2022Mr. Paul introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To terminate duties and other restrictions on the importation of infant formula, and for other purposes. 1. Short title This Act may be cited as the Freedom to Import Infant Formula Act of 2022. 2. Termination of duties and other restrictions on importation of infant formula (a) Duty-Free treatment of infant formula On and after the date of the enactment of this Act, infant formula classified under heading 1901.10 of the Harmonized Tariff Schedule of the United States shall enter the United States free of duty and free of quantitative limitation. (b) Importation of infant formula legal for sale in certain countries (1) In general Notwithstanding any other provision of law, with respect to infant formula from a country described in paragraph (2)— (A) U.S. Customs and Border Protection may not seize or otherwise enforce restrictions on the importation of such formula if such formula would meet the legal requirements for sale in that country; and (B) such formula is deemed to be in compliance with the requirements under section 412 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a). (2) Country described A country described in this paragraph is any of the following: (A) Australia. (B) Canada. (C) Israel. (D) Japan. (E) New Zealand. (F) The United Kingdom. (G) A member country of the European Union. (H) A member country of the European Economic Area. (c) Infant formula defined In this section, the term infant formula has the meaning given that term in section 201(z) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)).